APO[epsilon]4is associated with enhancedin vivoinnate immune responses in human subjects

Background The genetic determinants of the human innate immune response are poorly understood. Apolipoprotein (Apo) E, a lipid-trafficking protein that affects inflammation, has well-described wild-type ([straight epsilon]3) and disease-associated ([straight epsilon]2 and [straight epsilon]4) allele...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2014-07, Vol.134 (1), p.127
Hauptverfasser: Gale, Stephen C, Gao, Li, Mikacenic, Carmen, Coyle, Susette M, Rafaels, Nicholas, Murray Dudenkov, Tanda, Madenspacher, Jennifer H, Draper, David W, Ge, William, Aloor, Jim J, Azzam, Kathleen M, Lai, Lihua, Blackshear, Perry J, Calvan o, Steven E, Barnes, Kathleen C, Lowry, Stephen F, Corbett, Siobhan, Wurfel, Mark M, Fessler, Michael B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background The genetic determinants of the human innate immune response are poorly understood. Apolipoprotein (Apo) E, a lipid-trafficking protein that affects inflammation, has well-described wild-type ([straight epsilon]3) and disease-associated ([straight epsilon]2 and [straight epsilon]4) alleles, but its connection to human innate immunity is undefined. Objective We sought to define the relationship ofAPO[straight epsilon]4to the human innate immune response. Methods We evaluatedAPO[straight epsilon]4in several functional models of the human innate immune response, including intravenous LPS challenge in human subjects, and assessedAPO[straight epsilon]4association to organ injury in patients with severe sepsis, a disease driven by dysregulated innate immunity. Results Whole blood from healthyAPO[straight epsilon]3/APO[straight epsilon]4volunteers induced higher cytokine levels onex vivostimulation with Toll-like receptor (TLR) 2, TLR4, or TLR5 ligands than blood fromAPO[straight epsilon]3/APO[straight epsilon]3patients, whereas TLR7/8 responses were similar. This was associated with increased lipid rafts inAPO[straight epsilon]3/APO[straight epsilon]4monocytes. By contrast,APO[straight epsilon]3/APO[straight epsilon]3andAPO[straight epsilon]3/APO[straight epsilon]4serum neutralized LPS equivalently and supported similar LPS responses inApoe-deficient macrophages, arguing against a differential role for secretory APOE4 protein. After intravenous LPS,APO[straight epsilon]3/APO[straight epsilon]4patients had higher hyperthermia and plasma TNF-[alpha] levels and earlier plasma IL-6 thanAPO[straight epsilon]3/APO[straight epsilon]3patients. APOE4-targeted replacement mice displayed enhanced hypothermia, plasma cytokines, and hepatic injury and altered splenic lymphocyte apoptosis after systemic LPS compared with APOE3 counterparts. In a cohort of 828 patients with severe sepsis,APO[straight epsilon]4was associated with increased coagulation system failure among European American patients. Conclusions APO[straight epsilon]4is a determinant of the human innate immune response to multiple TLR ligands and associates with altered patterns of organ injury in human sepsis.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2014.01.032